13F filer · CIK 1618205
Birchview Capital, LP
BURLINGTON, VT · filing since Q4 2014 · last filing Aug 14, 2026
Reported value
$213.8M
+$38.2M vs prior
Positions
72
New / sold out
14 / 15
Added / reduced
18 / 21
Turnover
16.6%
buys $70.7M · sells $32.3M
Top-10 weight
59.9%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | KLA CORPORATION | +158,588 | +797.6% | +$47.8M |
| Added | NEKTAR THERAPEUTICS | +50,000 | +161.3% | +$3.5M |
| New | ABIVAX SA | +17,000 | – | +$2.3M |
| New | VIR BIOTECHNOLOGY INC | +220,000 | – | +$2.2M |
| Added | HALOZYME THERAPEUTICS INC | +23,151 | +229.2% | +$1.8M |
| New | BIOAGE LABS INC | +69,000 | – | +$1.7M |
| New | NOVO NORDISK A/S | +24,000 | – | +$1.2M |
| New | ADAGENE INC | +240,000 | – | +$1.0M |
| New | DEFINIUM THERAPEUTICS INC | +20,000 | – | +$940.8K |
| Added | CORCEPT THERAPEUTICS INC | +10,000 | +21.2% | +$869.5K |
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | COMPASS PATHWAYS LTD | -345,000 | -92.0% | $-4.9M |
| Reduced | STRUCTURE THERAPEUTICS INC | -76,000 | -76.0% | $-4.1M |
| Reduced | OCULAR THERAPEUTIX INC | -299,345 | -93.5% | $-2.9M |
| Reduced | UNIQURE NV | -50,000 | -49.7% | $-2.3M |
| Sold out | NOVOCURE LTD | -202,330 | -100.0% | $-2.2M |
| Sold out | ENGENE HOLDINGS INC | -250,000 | -100.0% | $-1.7M |
| Reduced | PHATHOM PHARMACEUTICALS INC | -140,000 | -71.8% | $-1.5M |
| Sold out | ULTRAGENYX PHARMACEUTICAL INC | -62,000 | -100.0% | $-1.3M |
| Sold out | KALVISTA PHARMACEUTICALS INC | -57,000 | -100.0% | $-1.1M |
| Reduced | INTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026 | -59,500 | -13.4% | $-1.0M |
26 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | KLA CORPORATIONCOM NEW | 178,471 | $53.8M | 25.18% |
| 2 | BRISTOL-MYERS SQUIBB COCOM | 297,243 | $17.1M | 8.01% |
| 3 | LAM RESEARCH CORPORATIONCOM NEW | 35,000 | $15.2M | 7.09% |
| 4 | INTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026COM | 385,900 | $6.8M | 3.17% |
| 5 | SOLID BIOSCIENCES INCCOM NEW | 666,196 | $6.7M | 3.11% |
| 6 | BIODESIX INCCOM | 286,804 | $6.5M | 3.02% |
| 7 | STOKE THERAPEUTICS INCCOM | 178,110 | $5.8M | 2.73% |
| 8 | OVINTIV INCCOM | 107,500 | $5.7M | 2.65% |
| 9 | NEKTAR THERAPEUTICSCOM | 81,000 | $5.7M | 2.64% |
| 10 | CORCEPT THERAPEUTICS INCCOM | 57,200 | $5.0M | 2.33% |
62 more rows. Subscribe for $29/month to see every row, download the data and use the API.